TrialBritish journal of cancer2023

Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.

Florence Duffaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.